Chardan Nextech Expands Biopharma Focus: New Coverage on Gossamer Bio, Inhibikase & Vicore Pharma Conference
Chardan Nextech Acquisition expands biopharma coverage, launching a buy on Gossamer Bio, neutral on Inhibikase, and hosts a Vicore Pharma panel on pulmonary therapy.
2 minutes to read